These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35855578)

  • 1. Micropapillary bladder cancer: an evolving biology.
    Lonati C; Simeone C; Suardi N; Briganti A; Montorsi F; Moschini M
    Curr Opin Urol; 2022 Sep; 32(5):504-510. PubMed ID: 35855578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micropapillary bladder cancer: current treatment patterns and review of the literature.
    Willis DL; Flaig TW; Hansel DE; Milowsky MI; Grubb RL; Al-Ahmadie HA; Plimack ER; Koppie TM; McConkey DJ; Dinney CP; Hoffman VA; Droller MJ; Messing E; Kamat AM
    Urol Oncol; 2014 Aug; 32(6):826-32. PubMed ID: 24931270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.
    Lonati C; Baumeister P; Afferi L; Mari A; Minervini A; Krajewski W; Azizi S; Hendricksen K; Martini A; Necchi A; Montorsi F; Briganti A; Colombo R; Tafuri A; Antonelli A; Cerruto MA; Rouprêt M; Masson-Lecomte A; Laukhtina E; D'Andrea D; Shariat SF; Soria F; Marra G; Gontero P; Contieri R; Hurle R; Valiquette AS; Mir MC; Zamboni S; Simeone C; Klatte T; Teoh JY; Yoshida S; Fujii Y; Carando R; Schulz GB; Mordasini L; Mattei A; Moschini M;
    Eur Urol Focus; 2022 Sep; 8(5):1270-1277. PubMed ID: 34419381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder.
    Rouanne M; Bajorin DF; Hannan R; Galsky MD; Williams SB; Necchi A; Sharma P; Powles T
    Eur Urol Oncol; 2020 Dec; 3(6):728-738. PubMed ID: 33177001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder.
    Ghoneim IA; Miocinovic R; Stephenson AJ; Garcia JA; Gong MC; Campbell SC; Hansel DE; Fergany AF
    Urology; 2011 Apr; 77(4):867-70. PubMed ID: 21296399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy.
    Hajiran A; Azizi M; Aydin AM; Zemp L; Peyton CC; Dhillon J; Nealon S; Reich RR; Cao B; Li R; Manley BJ; Sexton WJ; Gilbert SM
    J Urol; 2021 Jan; 205(1):100-108. PubMed ID: 32783489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.
    Fernández MI; Williams SB; Willis DL; Slack RS; Dickstein RJ; Parikh S; Chiong E; Siefker-Radtke AO; Guo CC; Czerniak BA; McConkey DJ; Shah JB; Pisters LL; Grossman HB; Dinney CP; Kamat AM
    BJU Int; 2017 May; 119(5):684-691. PubMed ID: 27753185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies.
    Necchi A; Raggi D; Gallina A; Madison R; Colecchia M; Lucianò R; Montironi R; Giannatempo P; Farè E; Pederzoli F; Bandini M; Bianchi M; Colombo R; Gandaglia G; Fossati N; Marandino L; Capitanio U; Dehò F; Ali SM; Chung JH; Ross JS; Salonia A; Briganti A; Montorsi F
    Eur Urol; 2020 Apr; 77(4):439-446. PubMed ID: 31708296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.
    Necchi A; Anichini A; Raggi D; Briganti A; Massa S; Lucianò R; Colecchia M; Giannatempo P; Mortarini R; Bianchi M; Farè E; Monopoli F; Colombo R; Gallina A; Salonia A; Messina A; Ali SM; Madison R; Ross JS; Chung JH; Salvioni R; Mariani L; Montorsi F
    J Clin Oncol; 2018 Dec; 36(34):3353-3360. PubMed ID: 30343614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
    Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micropapillary Bladder Cancer: Insights from the National Cancer Database.
    Sui W; Matulay JT; James MB; Onyeji IC; Theofanides MC; RoyChoudhury A; DeCastro GJ; Wenske S
    Bladder Cancer; 2016 Oct; 2(4):415-423. PubMed ID: 28035322
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
    Pokuri VK; Syed JR; Yang Z; Field EP; Cyriac S; Pili R; Levine EG; Azabdaftari G; Trump DL; Guru K; George S
    Clin Genitourin Cancer; 2016 Feb; 14(1):e59-65. PubMed ID: 26508364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.
    Spaliviero M; Dalbagni G; Bochner BH; Poon BY; Huang H; Al-Ahmadie HA; Donahue TF; Taylor JM; Meeks JJ; Sjoberg DD; Donat SM; Reuter VE; Herr HW
    J Urol; 2014 Sep; 192(3):702-7. PubMed ID: 24603101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
    Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
    Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial.
    Hinsenveld FJ; Noordman BJ; Boormans JL; Voortman J; van Leenders GJLH; van der Pas SL; van Beek SC; Oprea-Lager DE; Vis AN
    BMC Cancer; 2021 Oct; 21(1):1161. PubMed ID: 34715822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder.
    Hensley PJ; Goodwin J; Davenport DL; Strup SE; James A
    Clin Genitourin Cancer; 2018 Aug; 16(4):e851-e858. PubMed ID: 29548614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
    Necchi A; Raggi D; Gallina A; Ross JS; Farè E; Giannatempo P; Marandino L; Colecchia M; Lucianò R; Bianchi M; Colombo R; Salonia A; Gandaglia G; Fossati N; Bandini M; Pederzoli F; Capitanio U; Montorsi F; de Jong JJ; Dittamore R; Liu Y; Davicioni E; Boormans JL; Briganti A; Black PC; Gibb EA
    Eur Urol; 2020 Jun; 77(6):701-710. PubMed ID: 32165065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.
    Culp SH; Dickstein RJ; Grossman HB; Pretzsch SM; Porten S; Daneshmand S; Cai J; Groshen S; Siefker-Radtke A; Millikan RE; Czerniak B; Navai N; Wszolek MF; Kamat AM; Dinney CP
    J Urol; 2014 Jan; 191(1):40-7. PubMed ID: 23911605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
    Izawa JI; Chin JL; Winquist E
    Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.